According to Liene Luce, an expert from the Drug Safety Department of the Latvian Medicines Agency (ZVA), there has been a notable rise in reports of mild side effects from medications, including symptoms such as itching, dizziness, headaches, fatigue, drowsiness, diarrhea, and vomiting. These concerns are particularly relevant for drugs like immunosuppressants, which are used in the treatment of rheumatism, and GLP-1 receptor agonists, which are commonly prescribed for managing diabetes and obesity. Luce emphasized that many of these reports originate from initial suspicions raised by patients regarding their medications.

The information reported about drug side effects is systematically entered into a comprehensive database maintained by the European Union. This allows for further evaluation by medical specialists to determine whether the side effects truly correlate with the use of the medications in question. If the correlation is established, appropriate actions are taken, which might include revisions to the drug's usage instructions or labeling, or urgent public notifications in critical situations.

This growing trend of reporting highlights the importance of monitoring and understanding the risk factors associated with medication use. With an increase in the consumption of medications, healthcare authorities must remain vigilant in assessing drug safety to protect public health, ensuring that both healthcare providers and patients are aware of potential side effects that could affect their health outcomes.